Transcription
Robert Kieval 0:09
Hi, good morning. My name is Robert Kieval with Veranex, and I co-lead our strategic partnerships practice. Until late 2021. I was with IMMR, a Paris based preclinical science organization, where I was CEO of our North American headquarters based in Minneapolis. And then in late 2021 I MMR was acquired by Raleigh, North Carolina based Varenex and we joined Veranex growing family of companies. To date, Veranex has thoughtfully brought together seven world class companies to become the leading provider of product development and commercialization services in medtech, and we're continuing to grow. In fact, you may have seen our press release from earlier this week announcing our acquisition of Lausanne based MediA, a top three provider of Regulatory Affairs, quality assurance and clinical consulting services to further strengthen our European presence. Veranex was purpose built as an end to end platform to serve the product development and commercialization needs of companies developing new medical technologies are thus far seven companies are uniting under the very next brand with offerings that include product design and engineering, preclinical services, clinical development services and associated data management and analytics, regulatory affairs and quality systems management, and importantly, market access and commercial strategy. Our product design and engineering services are provided by the teams from our acquisitions of Zai, medica and Warrell with offices in Providence, Rhode Island, Minneapolis, London and Shanghai. Our preclinical services, as I mentioned, are provided by IMMR in our Paris based FDA inspected fully a lack of credited and now OECD GLP certified preclinical laboratories. End to End clinical development services are provided by the teams of California based Experian group, Princeton, New Jersey based Cartesian and now also Lausanne based MediA our newest partner. Cartesian also provides sophisticated data management and analytic services to help support large clinical trials and digital health applications. Our experts from experience and now many day bring deep expertise in regulatory affairs and quality systems management across all stages of product development and throughout the product lifecycle, including importantly here in Europe, eu MDR remediation include clinical evidence report submissions. And finally, our market access and commercial strategy services are provided by the team from Boston healthcare associates, based in Massachusetts, with offices in Berlin. So collectively, we have deep experience across multiple therapeutic areas and diverse technology categories. And while very next itself is a young company, our legacy businesses have literally decades of experience to draw from. So what's changed is that Veranex has established a new standard for providing product development and commercialization services at scale in the med tech space, offering unique efficiencies and advantages. Importantly, what haven't changed are our people, our relationships with our clients, our commitment to your success, and the caliber of the work that you've come to experience working with us individually, and that you'll continue to experience working with us as Veranex, and we welcome the opportunity to prove that to you. Thank you
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
